The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

European Urology(2022)

引用 12|浏览17
暂无评分
摘要
1. SEMITEP assessed whether men with good-prognosis metastatic seminoma could be treated with fewer cycles of chemotherapy based on interim fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
更多
查看译文
关键词
Testis cancer,Seminoma,Fluorodeoxyglucose positron emission tomography,Chemotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要